UK-India FTA is a missed opportunity for IP protection, AstraZeneca exec says
AstraZeneca executive Mike Archer said on Tuesday that the UK-India Free Trade Agreement has failed to address recognized issues with India’s stance towards third-country IP, stymying hopes that the FTA would...To view the full article, register now.
Already a subscriber? Click here to view full article